Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Clinical trial NCT00362349 · COMPLETED

Trial details

NCT number: NCT00362349
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura (ITP)

Start date: 2007-06-01
Primary completion: 2008-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.